1. Home
  2. HBM vs RGEN Comparison

HBM vs RGEN Comparison

Compare HBM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudbay Minerals Inc. (Canada)

HBM

Hudbay Minerals Inc. (Canada)

HOLD

Current Price

$25.84

Market Cap

9.8B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$143.75

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBM
RGEN
Founded
1927
1981
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HBM
RGEN
Price
$25.84
$143.75
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$21.25
$177.18
AVG Volume (30 Days)
6.8M
680.2K
Earning Date
02-20-2026
02-19-2026
Dividend Yield
0.06%
N/A
EPS Growth
396.15
N/A
EPS
1.16
0.03
Revenue
$2,063,000,000.00
$707,890,000.00
Revenue This Year
$10.83
$17.86
Revenue Next Year
$12.19
$12.44
P/E Ratio
$21.30
$5,587.52
Revenue Growth
1.20
11.74
52 Week Low
$5.95
$102.97
52 Week High
$28.74
$175.77

Technical Indicators

Market Signals
Indicator
HBM
RGEN
Relative Strength Index (RSI) 59.24 32.55
Support Level $23.40 $138.52
Resistance Level $27.06 $160.88
Average True Range (ATR) 1.42 7.17
MACD -0.22 -2.22
Stochastic Oscillator 45.24 14.52

Price Performance

Historical Comparison
HBM
RGEN

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: